Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Safety of Oral P2Y12 Inhibitors in Interventional Neuroradiology: Current Status and Perspectives
- Relationship between adverse events and antiplatelet drug resistance in neurovascular intervention: a meta-analysis
- Clopidogrel Resistance in Neurovascular Stenting: Correlations between Light Transmission Aggregometry, VerifyNow, and the Multiplate
- Use of thromboelastography to tailor dual-antiplatelet therapy in patients undergoing treatment of intracranial aneurysms with the Pipeline embolization device
- Tailoring platelet inhibition according to multiple electrode aggregometry decreases the rate of thrombotic complications after intracranial flow-diverting stent implantation
- Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms
- Incidence of Microemboli and Correlation with Platelet Inhibition in Aneurysmal Flow Diversion
- Clopidogrel Hyper-Response and Bleeding Risk in Neurointerventional Procedures
- Clopidogrel Resistance Is Associated with Thromboembolic Complications in Patients Undergoing Neurovascular Stenting
- Platelet-Function Testing in Patients Undergoing Neurovascular Procedures: Caught between a Rock and a Hard Place
- Body weight: a risk factor for subtherapeutic antithrombotic therapy in neurovascular stenting
- Neuroform Stent-Assisted Coiling of Unruptured Intracranial Aneurysms: Short- and Midterm Results from a Single-Center Experience with 68 Patients
- Stent-Assisted Coiling of Intracranial Aneurysms: Clinical and Angiographic Results in 216 Consecutive Aneurysms
- Advances in Interventional Neuroradiology